| An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 DR Owen, CMN Allerton, AS Anderson, L Aschenbrenner, M Avery, ... Science 374 (6575), 1586-1593, 2021 | 1330 | 2021 |
| Comparison of various international guidelines for analytical method validation S Chandran, RSP Singh Die Pharmazie-An International Journal of Pharmaceutical Sciences 62 (1), 4-14, 2007 | 305 | 2007 |
| Innovative randomized phase I study and dosing regimen selection to accelerate and inform pivotal COVID‐19 trial of nirmatrelvir RSP Singh, SS Toussi, F Hackman, PL Chan, R Rao, R Allen, L Van Eyck, ... Clinical Pharmacology & Therapeutics 112 (1), 101-111, 2022 | 92 | 2022 |
| Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans H Eng, AL Dantonio, EP Kadar, RS Obach, L Di, J Lin, NC Patel, B Boras, ... Drug Metabolism and Disposition 50 (5), 576-590, 2022 | 76 | 2022 |
| Stability indicating ultraviolet spectroscopic method for the estimation of ezetimibe and carvedilol M Imran, RSP Singh, S Chandran Die Pharmazie-An International Journal of Pharmaceutical Sciences 61 (9 …, 2006 | 53 | 2006 |
| Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis RR Kempker, AB Barth, S Vashakidze, K Nikolaishvili, I Sabulua, ... Antimicrobial agents and chemotherapy 59 (6), 3149-3155, 2015 | 47 | 2015 |
| A general HPLC–UV method for the quantitative determination of curcumin analogues containing the 1, 5-diaryl-3-oxo-1, 4-pentadienyl pharmacophore in rat biomatrices RSP Singh, U Das, JR Dimmock, J Alcorn Journal of Chromatography B 878 (28), 2796-2802, 2010 | 41 | 2010 |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple … SI Danto, N Shojaee, RSP Singh, C Li, SA Gilbert, Z Manukyan, I Kilty Arthritis research & therapy 21 (1), 1-17, 2019 | 39 | 2019 |
| Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques RK Verma, JK Mukker, RSP Singh, K Kumar, PRP Verma, A Misra Molecular pharmaceutics 9 (4), 1011-1016, 2012 | 39 | 2012 |
| Comparison of skin permeability for three diclofenac topical formulations: an in vitro study E Folzer, D Gonzalez, R Singh, H Derendorf Die Pharmazie-An International Journal of Pharmaceutical Sciences 69 (1), 27-31, 2014 | 34 | 2014 |
| A basic fibroblast growth factor analog for protection and mitigation against acute radiation syndromes K Casey-Sawicki, M Zhang, S Kim, A Zhang, SB Zhang, Z Zhang, R Singh, ... Health Physics 106 (6), 704-712, 2014 | 33 | 2014 |
| Determination of atypical nonlinear plasma–protein-binding behavior of tigecycline using an in vitro microdialysis technique JK Mukker, RP Singh, H Derendorf Journal of Pharmaceutical Sciences 103 (3), 1013-1019, 2014 | 33 | 2014 |
| Ciclesonide: a pro-soft drug approach for mitigation of side effects of inhaled corticosteroids JK Mukker, RSP Singh, H Derendorf Journal of Pharmaceutical Sciences 105 (9), 2509-2514, 2016 | 31 | 2016 |
| Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats JK Mukker, RSP Singh, AD Muir, ES Krol, J Alcorn British Journal of Nutrition 113 (5), 749-757, 2015 | 30 | 2015 |
| HPLC method with fluorescence detection for the quantitative determination of flaxseed lignans JK Mukker, V Kotlyarova, RSP Singh, J Alcorn Journal of Chromatography B 878 (30), 3076-3082, 2010 | 29 | 2010 |
| Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b … C Tehlirian, RSP Singh, V Pradhan, ES Roberts, S Tarabar, E Peeva, ... Journal of the American Academy of Dermatology 87 (2), 333-342, 2022 | 28 | 2022 |
| Nonlinear protein binding: not what you think AN Deitchman, RSP Singh, H Derendorf Journal of pharmaceutical sciences 107 (7), 1754-1760, 2018 | 28 | 2018 |
| Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy JK Mukker, RSP Singh, H Derendorf Advanced drug delivery reviews 85, 57-64, 2015 | 25 | 2015 |
| Largazole pharmacokinetics in rats by LC-MS/MS M Yu, LA Salvador, SKB Sy, Y Tang, RSP Singh, QY Chen, Y Liu, J Hong, ... Marine Drugs 12 (3), 1623-1640, 2014 | 23 | 2014 |
| Development and validation of a rapid, sensitive liquid chromatography–tandem mass spectrometry method using electrospray ionization for quantitation of centchroman in rat … SP Singh, RSP Singh, GK Jain Journal of Chromatography B 876 (1), 1-7, 2008 | 23 | 2008 |
Hartmut DerendorfDistinguished Professor of Pharmaceutics, University of FloridaDirección de correo verificada de ufl.edu
